Suppr超能文献

细胞间黏附分子 1 介导的黏附是外泌体诱导 T 细胞抑制的前提条件。

ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression.

机构信息

Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Dev Cell. 2022 Feb 7;57(3):329-343.e7. doi: 10.1016/j.devcel.2022.01.002. Epub 2022 Jan 31.

Abstract

Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8 T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.

摘要

肿瘤来源的细胞外囊泡 (TEV) 抑制 CD8 T 细胞的增殖和细胞毒性,从而促进肿瘤免疫逃逸。在这里,我们报告黏附分子细胞间黏附分子 1 (ICAM-1) 与程序性死亡配体 1 (PD-L1) 在细胞外囊泡上共定位;干扰素-γ可上调 ICAM-1 和 PD-L1。细胞外囊泡上的 ICAM-1 与在活化 T 细胞中上调的 LFA-1 相互作用。阻断 TEV 上的 ICAM-1 可减少 TEV 与 CD8 T 细胞的相互作用,并减弱 TEV 介导的 PD-L1 抑制作用。在这项研究中,我们建立了一种通过 SorTagging(ETIDS)系统检测细胞外囊泡-靶细胞相互作用的方法,以评估 TEV 配体与其靶细胞受体之间的相互作用。使用该系统,我们证明在没有 ICAM-1 的情况下,TEV PD-L1 与 T 细胞上的程序性细胞死亡 1 (PD-1) 的相互作用显著减少。我们的研究表明,TEV 和 T 细胞之间的 ICAM-1-LFA-1 介导的黏附是细胞外 PD-L1 介导的免疫抑制的先决条件。

相似文献

引用本文的文献

6
Extracellular vesicles as biomarkers and drug delivery systems for tumor.细胞外囊泡作为肿瘤的生物标志物和药物递送系统
Acta Pharm Sin B. 2025 Jul;15(7):3460-3486. doi: 10.1016/j.apsb.2025.04.033. Epub 2025 May 10.

本文引用的文献

1
Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy.外泌体 PD-L1:在肿瘤进展和免疫治疗中的作用。
Trends Cancer. 2020 Jul;6(7):550-558. doi: 10.1016/j.trecan.2020.03.002. Epub 2020 Mar 29.
3
Top 10 Challenges in Cancer Immunotherapy.癌症免疫疗法的十大挑战。
Immunity. 2020 Jan 14;52(1):17-35. doi: 10.1016/j.immuni.2019.12.011.
10
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.免疫检查点阻断治疗的基本机制。
Cancer Discov. 2018 Sep;8(9):1069-1086. doi: 10.1158/2159-8290.CD-18-0367. Epub 2018 Aug 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验